InMode Ltd. (INMD)
NASDAQ: INMD · Real-Time Price · USD
15.59
-0.42 (-2.62%)
At close: Oct 22, 2025, 4:00 PM EDT
15.90
+0.31 (1.99%)
After-hours: Oct 22, 2025, 7:24 PM EDT
InMode Revenue
InMode had revenue of $95.60M in the quarter ending June 30, 2025, with 10.59% growth. This brings the company's revenue in the last twelve months to $401.56M, down -3.62% year-over-year. In the year 2024, InMode had annual revenue of $394.82M, down -19.76%.
Revenue (ttm)
$401.56M
Revenue Growth
-3.62%
P/S Ratio
2.73
Revenue / Employee
$670,386
Employees
599
Market Cap
985.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 394.82M | -97.23M | -19.76% |
| Dec 31, 2023 | 492.05M | 37.78M | 8.32% |
| Dec 31, 2022 | 454.27M | 96.71M | 27.05% |
| Dec 31, 2021 | 357.57M | 151.46M | 73.49% |
| Dec 31, 2020 | 206.11M | 49.75M | 31.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
INMD News
- 13 days ago - InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M - PRNewsWire
- 6 weeks ago - DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders - PRNewsWire
- 7 weeks ago - InMode to Present at Baird 2025 Global Healthcare Conference - PRNewsWire
- 2 months ago - InMode to Participate in Upcoming Investor Conferences - PRNewsWire
- 3 months ago - InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins - PRNewsWire
- 3 months ago - InMode: Margin Pressure, But Optionality Makes It Worth A Look - Seeking Alpha
- 3 months ago - InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M - PRNewsWire